1
Luyendijk, Marianne, Blommestein, Hedwig, Uyl-de Groot, Carin, Siesling, Sabine, Jager, Agnes
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
2
Franken, Margreet, Kanters, Tim, Coenen, JL, De Jong, P, Koene, HR, Lugtenburg, Elly, Jager, Agnes, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
3
Kleijburg, Anne, Braal, C. Louwrens, Westenberg, Justin D., Jager, Agnes, Koolen, Stijn L.W., Mathijssen, Ron H.J., Uyl-de Groot, Carin A., Wetzelaer, Pim, Penton, Hannah
Veröffentlicht in: Kleijburg , A , Braal , C L , Westenberg , J D , Jager , A , Koolen , S L W , Mathijssen , R H J , Uyl-de Groot , C A , Wetzelaer , P & Penton , H 2023 , ' Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands ' , Biomedicine and Pharmacotherapy , vol. 158 , 114158 . https://doi.org/10.1016/j.biopha.2022.114158;
2023
Veröffentlicht in: Kleijburg , A , Braal , C L , Westenberg , J D , Jager , A , Koolen , S L W , Mathijssen , R H J , Uyl-de Groot , C A , Wetzelaer , P & Penton , H 2023 , ' Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands ' , Biomedicine and Pharmacotherapy , vol. 158 , 114158 . https://doi.org/10.1016/j.biopha.2022.114158;
2023